Logo image of MDB

MONGODB INC (MDB) Stock Fundamental Analysis

NASDAQ:MDB - Nasdaq - US60937P1066 - Common Stock - Currency: USD

201.5  -2.65 (-1.3%)

After market: 201.45 -0.05 (-0.02%)

Fundamental Rating

4

MDB gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 82 industry peers in the IT Services industry. No worries on liquidiy or solvency for MDB as it has an excellent financial health rating, but there are worries on the profitability. While showing a medium growth rate, MDB is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year MDB was profitable.
MDB had a positive operating cash flow in the past year.
MDB had negative earnings in each of the past 5 years.
In multiple years MDB reported negative operating cash flow during the last 5 years.
MDB Yearly Net Income VS EBIT VS OCF VS FCFMDB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M -200M -300M

1.2 Ratios

MDB has a Return On Assets of -2.38%. This is in the lower half of the industry: MDB underperforms 63.41% of its industry peers.
Looking at the Return On Equity, with a value of -2.84%, MDB is in line with its industry, outperforming 42.68% of the companies in the same industry.
Industry RankSector Rank
ROA -2.38%
ROE -2.84%
ROIC N/A
ROA(3y)-7.75%
ROA(5y)-10.95%
ROE(3y)-22.62%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MDB Yearly ROA, ROE, ROICMDB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20K 40K 60K 80K

1.3 Margins

With an excellent Gross Margin value of 72.89%, MDB belongs to the best of the industry, outperforming 89.02% of the companies in the same industry.
MDB's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for MDB so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 72.89%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.41%
GM growth 5Y0.85%
MDB Yearly Profit, Operating, Gross MarginsMDB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100 -150

More info and screens

8

2. Health

2.1 Basic Checks

MDB does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, MDB has more shares outstanding
MDB has more shares outstanding than it did 5 years ago.
MDB has a better debt/assets ratio than last year.
MDB Yearly Shares OutstandingMDB Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
MDB Yearly Total Debt VS Total AssetsMDB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

2.2 Solvency

An Altman-Z score of 17.22 indicates that MDB is not in any danger for bankruptcy at the moment.
MDB has a better Altman-Z score (17.22) than 96.34% of its industry peers.
MDB has a debt to FCF ratio of 0.21. This is a very positive value and a sign of high solvency as it would only need 0.21 years to pay back of all of its debts.
MDB has a Debt to FCF ratio of 0.21. This is amongst the best in the industry. MDB outperforms 91.46% of its industry peers.
A Debt/Equity ratio of 0.01 indicates that MDB is not too dependend on debt financing.
MDB has a better Debt to Equity ratio (0.01) than 81.71% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.21
Altman-Z 17.22
ROIC/WACCN/A
WACC9.28%
MDB Yearly LT Debt VS Equity VS FCFMDB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

MDB has a Current Ratio of 5.89. This indicates that MDB is financially healthy and has no problem in meeting its short term obligations.
MDB has a Current ratio of 5.89. This is amongst the best in the industry. MDB outperforms 91.46% of its industry peers.
MDB has a Quick Ratio of 5.89. This indicates that MDB is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of MDB (5.89) is better than 91.46% of its industry peers.
Industry RankSector Rank
Current Ratio 5.89
Quick Ratio 5.89
MDB Yearly Current Assets VS Current LiabilitesMDB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 26.99% over the past year.
The Revenue has grown by 19.24% in the past year. This is quite good.
Measured over the past years, MDB shows a very strong growth in Revenue. The Revenue has been growing by 36.61% on average per year.
EPS 1Y (TTM)26.99%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%96.08%
Revenue 1Y (TTM)19.24%
Revenue growth 3Y31.93%
Revenue growth 5Y36.61%
Sales Q2Q%21.85%

3.2 Future

The Earnings Per Share is expected to grow by 11.81% on average over the next years. This is quite good.
MDB is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 16.10% yearly.
EPS Next Y-14.35%
EPS Next 2Y0.81%
EPS Next 3Y10.29%
EPS Next 5Y11.81%
Revenue Next Year15.72%
Revenue Next 2Y15.82%
Revenue Next 3Y17.07%
Revenue Next 5Y16.1%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
MDB Yearly Revenue VS EstimatesMDB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2B 4B 6B
MDB Yearly EPS VS EstimatesMDB Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 5 10

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 48.67 indicates a quite expensive valuation of MDB.
The rest of the industry has a similar Price/Earnings ratio as MDB.
MDB is valuated expensively when we compare the Price/Earnings ratio to 26.35, which is the current average of the S&P500 Index.
MDB is valuated quite expensively with a Price/Forward Earnings ratio of 54.32.
MDB's Price/Forward Earnings is on the same level as the industry average.
When comparing the Price/Forward Earnings ratio of MDB to the average of the S&P500 Index (22.19), we can say MDB is valued expensively.
Industry RankSector Rank
PE 48.67
Fwd PE 54.32
MDB Price Earnings VS Forward Price EarningsMDB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

MDB's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 99.25
EV/EBITDA N/A
MDB Per share dataMDB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y0.81%
EPS Next 3Y10.29%

More info and screens

0

5. Dividend

5.1 Amount

MDB does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MONGODB INC

NASDAQ:MDB (6/20/2025, 8:00:00 PM)

After market: 201.45 -0.05 (-0.02%)

201.5

-2.65 (-1.3%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)06-04 2025-06-04/amc
Earnings (Next)08-27 2025-08-27/amc
Inst Owners87.52%
Inst Owner Change20.58%
Ins Owners0.85%
Ins Owner Change4.43%
Market Cap16.46B
Analysts79.51
Price Target285.24 (41.56%)
Short Float %3.42%
Short Ratio1.02
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)70.76%
Min EPS beat(2)49.98%
Max EPS beat(2)91.53%
EPS beat(4)4
Avg EPS beat(4)62%
Min EPS beat(4)40.33%
Max EPS beat(4)91.53%
EPS beat(8)8
Avg EPS beat(8)68.76%
EPS beat(12)12
Avg EPS beat(12)141.4%
EPS beat(16)16
Avg EPS beat(16)136.54%
Revenue beat(2)2
Avg Revenue beat(2)3.7%
Min Revenue beat(2)2.91%
Max Revenue beat(2)4.5%
Revenue beat(4)4
Avg Revenue beat(4)3.67%
Min Revenue beat(4)1.99%
Max Revenue beat(4)5.3%
Revenue beat(8)8
Avg Revenue beat(8)4.21%
Revenue beat(12)12
Avg Revenue beat(12)5.03%
Revenue beat(16)16
Avg Revenue beat(16)5.74%
PT rev (1m)2.07%
PT rev (3m)-22.34%
EPS NQ rev (1m)11.67%
EPS NQ rev (3m)9.8%
EPS NY rev (1m)18.89%
EPS NY rev (3m)-7.42%
Revenue NQ rev (1m)0.46%
Revenue NQ rev (3m)0.39%
Revenue NY rev (1m)0.61%
Revenue NY rev (3m)-1.62%
Valuation
Industry RankSector Rank
PE 48.67
Fwd PE 54.32
P/S 7.82
P/FCF 99.25
P/OCF 83.79
P/B 5.43
P/tB 5.89
EV/EBITDA N/A
EPS(TTM)4.14
EY2.05%
EPS(NY)3.71
Fwd EY1.84%
FCF(TTM)2.03
FCFY1.01%
OCF(TTM)2.4
OCFY1.19%
SpS25.76
BVpS37.12
TBVpS34.24
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.38%
ROE -2.84%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 72.89%
FCFM 7.88%
ROA(3y)-7.75%
ROA(5y)-10.95%
ROE(3y)-22.62%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.41%
GM growth 5Y0.85%
F-Score5
Asset Turnover0.58
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.21
Debt/EBITDA N/A
Cap/Depr 188.93%
Cap/Sales 1.45%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.89
Quick Ratio 5.89
Altman-Z 17.22
F-Score5
WACC9.28%
ROIC/WACCN/A
Cap/Depr(3y)83.49%
Cap/Depr(5y)72.21%
Cap/Sales(3y)0.8%
Cap/Sales(5y)1.06%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)26.99%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%96.08%
EPS Next Y-14.35%
EPS Next 2Y0.81%
EPS Next 3Y10.29%
EPS Next 5Y11.81%
Revenue 1Y (TTM)19.24%
Revenue growth 3Y31.93%
Revenue growth 5Y36.61%
Sales Q2Q%21.85%
Revenue Next Year15.72%
Revenue Next 2Y15.82%
Revenue Next 3Y17.07%
Revenue Next 5Y16.1%
EBIT growth 1Y34.91%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year2.27%
EBIT Next 3Y23.66%
EBIT Next 5Y36.16%
FCF growth 1Y594.95%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y573.2%
OCF growth 3Y178.14%
OCF growth 5YN/A